These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. STAT5 drives abnormal proliferation in autosomal dominant polycystic kidney disease. Fragiadaki M; Lannoy M; Themanns M; Maurer B; Leonhard WN; Peters DJ; Moriggl R; Ong AC Kidney Int; 2017 Mar; 91(3):575-586. PubMed ID: 28104302 [TBL] [Abstract][Full Text] [Related]
11. Mitochondrial Abnormality Facilitates Cyst Formation in Autosomal Dominant Polycystic Kidney Disease. Ishimoto Y; Inagi R; Yoshihara D; Kugita M; Nagao S; Shimizu A; Takeda N; Wake M; Honda K; Zhou J; Nangaku M Mol Cell Biol; 2017 Dec; 37(24):. PubMed ID: 28993480 [TBL] [Abstract][Full Text] [Related]
12. Double inhibition of cAMP and mTOR signalling may potentiate the reduction of cell growth in ADPKD cells. de Stephanis L; Bonon A; Varani K; Lanza G; Gafà R; Pinton P; Pema M; Somlo S; Boletta A; Aguiari G Clin Exp Nephrol; 2017 Apr; 21(2):203-211. PubMed ID: 27278932 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-1 receptor activation aggravates autosomal dominant polycystic kidney disease by modulating regulated necrosis. Yang B; Fu L; Privratsky JR; Lu X; Ren J; Mei C; Crowley SD Am J Physiol Renal Physiol; 2019 Aug; 317(2):F221-F228. PubMed ID: 31141402 [TBL] [Abstract][Full Text] [Related]
14. The C-terminal tail of polycystin-1 regulates complement factor B expression by signal transducer and activator of transcription 1. Wu M; Chen M; Jing Y; Gu J; Mei S; Yao Q; Zhou J; Yang M; Sun L; Wang W; Hu H; Wüthrich RP; Mei C Am J Physiol Renal Physiol; 2016 Jun; 310(11):F1284-94. PubMed ID: 26984954 [TBL] [Abstract][Full Text] [Related]
15. Extracellular vesicles and exosomes generated from cystic renal epithelial cells promote cyst growth in autosomal dominant polycystic kidney disease. Ding H; Li LX; Harris PC; Yang J; Li X Nat Commun; 2021 Jul; 12(1):4548. PubMed ID: 34315885 [TBL] [Abstract][Full Text] [Related]
16. The regulatory 1α subunit of protein kinase A modulates renal cystogenesis. Ye H; Wang X; Constans MM; Sussman CR; Chebib FT; Irazabal MV; Young WF; Harris PC; Kirschner LS; Torres VE Am J Physiol Renal Physiol; 2017 Sep; 313(3):F677-F686. PubMed ID: 28615245 [TBL] [Abstract][Full Text] [Related]
17. Macrophage Migration Inhibitory Factor Limits Renal Inflammation and Fibrosis by Counteracting Tubular Cell Cycle Arrest. Djudjaj S; Martin IV; Buhl EM; Nothofer NJ; Leng L; Piecychna M; Floege J; Bernhagen J; Bucala R; Boor P J Am Soc Nephrol; 2017 Dec; 28(12):3590-3604. PubMed ID: 28801314 [TBL] [Abstract][Full Text] [Related]
18. Berberine slows cell growth in autosomal dominant polycystic kidney disease cells. Bonon A; Mangolini A; Pinton P; Del Senno L; Aguiari G Biochem Biophys Res Commun; 2013 Nov; 441(3):668-74. PubMed ID: 24184483 [TBL] [Abstract][Full Text] [Related]
19. The chloride channel CFTR is not required for cyst growth in an ADPKD mouse model. Talbi K; Cabrita I; Kraus A; Hofmann S; Skoczynski K; Kunzelmann K; Buchholz B; Schreiber R FASEB J; 2021 Oct; 35(10):e21897. PubMed ID: 34473378 [TBL] [Abstract][Full Text] [Related]
20. Rapamycin treatment dose-dependently improves the cystic kidney in a new ADPKD mouse model via the mTORC1 and cell-cycle-associated CDK1/cyclin axis. Li A; Fan S; Xu Y; Meng J; Shen X; Mao J; Zhang L; Zhang X; Moeckel G; Wu D; Wu G; Liang C J Cell Mol Med; 2017 Aug; 21(8):1619-1635. PubMed ID: 28244683 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]